93 unknown. 93 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 93 | Unknown 93 |
Follow Hypersensitivity: new trials by email Literature Review of Hypersensitivity trials Research Report on Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients Dupilumab, Tofacitinib - Atopic Dermatitis | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 220 | 2025-01-01 | 2024-06-20 |
| Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps Dupilumab, Placebo - Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Unknown | Dr. Andrew Thamboo, MD | 60 | 2024-08-01 | 2024-08-16 |
| Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU) human histaglobulin, placebo, Loratadine 10 Mg - Chronic Spontaneous Urticaria | Phase 4 | Unknown | Hangzhou Grand Biologic Pharmaceutical, Inc. | 252 | 2024-03-31 | 2024-02-09 |
| NOVAPAK Nasal Packing in Shellfish Allergic Patients NOVAPAK nasal packing applied to forearm, NOVAPAK nasal packing applied to nasal cavity - Shellfish Hypersensitivity, Epistaxis | Phase 4 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 20 | 2024-03-15 | 2023-09-11 |
| Over-the-Counter Antihistamines & Heat Stress 50 mg Diphenhydramine, 10 mg Loratadine, 5 mg Desloratadine - Heat Illness, Allergic Rhinitis | Phase 4 | Unknown | Lakehead University | 16 | 2023-12-05 | 2024-01-22 |
| Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models Second-line systemic treatment, Folllow-up of second-line systemic treatment already started - Atopic Dermatitis | Phase 4 | Unknown | Instituto de Investigación Hospital Universitario La Paz | 150 | 2023-09-25 | 2024-04-16 |
| Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment Mepolizumab, Placebo - Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Unknown | St. Paul's Sinus Centre | 90 | 2023-07-01 | 2024-04-17 |
| Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma Azithromycin, ICS/LABA - Asthma, Chest Syndrome | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 248 | 2023-01-01 | 2022-11-04 |
| Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis Dicloxacillin Oral Capsule, Elocon 0.1 % Topical Cream - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Unknown | Jacob Pontoppidan Thyssen | 45 | 2022-10-24 | 2022-12-21 |
| Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response Cyclosporin A, Follow-up of Cyclospoin treatment already started - Atopic Dermatitis | Phase 4 | Unknown | Instituto de Investigación Hospital Universitario La Paz | 100 | 2022-10-10 | 2023-04-28 |
| Efficacy of Artemisia Pollen Specific Allergen Immunotherapy AIT drops, Clarityne, Rhinocort and Emedastine Difumarate Eye Drops - Allergic Rhinitis | Phase 4 | Unknown | Beijing Tongren Hospital | 150 | 2022-03-31 | 2022-05-26 |
| Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. Dupilumab, Optical Coherence Tomography, Reflectance confocal microscopy - Eczema, Atopic Dermatitis | Phase 4 | Unknown | OptiSkin Medical | 15 | 2022-03-01 | 2022-03-03 |
| Molecular Endotypes of Chronic Idiopathic Urticaria Omalizumab - Chronic Urticaria, Idiopathic | Phase 4 | Unknown | University of Colorado, Denver | 15 | 2022-01-01 | 2024-08-15 |
| Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood Methotrexate therapy, Mycophenolate mofetil therapy, Cyclosporine therapy - Atopic Dermatitis | Phase 4 | Unknown | National Medical Research Center for Children's Health, Russian Federation | 160 | 2021-11-25 | 2021-05-20 |
| Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma Salmeterol Xinafoate, Salmeterol Fluticasone - Asthma | Phase 4 | Unknown | Imperial College London | 24 | 2021-07-23 | 2023-04-25 |
| Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis Bencycloquidium Bromide Nasal Spray, Mometasone Furoate Aqueous Nasal Spray - Allergic Rhinitis | Phase 4 | Unknown | Yingu Pharmaceutical Co., Ltd | 450 | 2021-06-16 | 2024-03-04 |
| Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients. anti IL5 receptor antibodies - Severe Asthma | Phase 4 | Unknown | Scarlata, Simone, M.D. | 80 | 2021-03-18 | 2021-08-12 |
| Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age - Allergic Rhinitis | Phase 4 | Unknown | Usama Azhar | 60 | 2020-12-12 | 2021-07-12 |
| Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) Omeprazole 20mg BID - Eosinophilic Esophagitis | Phase 4 | Unknown | University of Colorado, Denver | 90 | 2020-10-07 | 2024-07-03 |
| An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis Dupilumab Only Product - Atopic Dermatitis, AD | Phase 4 | Unknown | Eric Simpson | 45 | 2020-09-01 | 2020-08-20 |
Showing 20 of 93. Sign in to see all of them.
Asthma (42) · Dermatitis, Atopic (12) · Rhinitis, Allergic (8) · Cough-Variant Asthma (6) · Conjunctivitis, Allergic (5) · Chronic Urticaria (4) · Sarcoidosis (4) · Urticaria (4) · Pulmonary Disease, Chronic Obstructive (3) · Pulmonary Eosinophilia (3) · Rhinitis, Allergic, Seasonal (3) · Sarcoidosis, Pulmonary (3) · Eczema (2) · Eosinophilic Esophagitis (2)
Immune System Diseases (92) · Hypersensitivity, Immediate (84) · Respiratory Tract Diseases (64) · Respiratory Hypersensitivity (58) · Lung Diseases (50) · Bronchial Diseases (47) · Lung Diseases, Obstructive (45) · Skin Diseases (18) · Skin and Connective Tissue Diseases (18) · Nose Diseases (14) · Otorhinolaryngologic Diseases (14) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Genetic Diseases, Inborn (12) · Rhinitis (12)
Budesonide (6) · dupilumab (6) · Budesonide, Formoterol Fumarate Drug Combination (5) · Omalizumab (5) · Formoterol Fumarate (4) · Mometasone Furoate (3) · levocetirizine (3) · mepolizumab (3) · Albuterol (2) · Azithromycin (2) · BID protein, human (2) · Fluticasone (2) · Loratadine (2) · Methacholine Chloride (2) · Omeprazole (2)
Medical University of Lodz (5) · Bispebjerg Hospital (4) · Second Affiliated Hospital, Zhejiang University, School of Medicine (4) · University of Cincinnati (4) · The First Affiliated Hospital of Guangzhou Medical University (3) · Zhujiang Hospital (3) · Creighton University (2) · Hom, Milton M., OD, FAAO (2) · Instituto de Investigación Hospital Universitario La Paz (2) · University of Colorado, Denver (2) · ACO Hud Nordic AB (1) · Al-Azhar University (1) · All India Institute of Medical Sciences (1) · Allergy and Asthma Center of El Paso (1) · Asan Medical Center (1)
United States (19) · China (13) · Canada (6) · Denmark (5) · Poland (5) · Brazil (3) · Italy (3) · Spain (3) · Belgium (2) · Bulgaria (2) · India (2) · Mexico (2) · Netherlands (2) · Taiwan (2) · United Kingdom (2)
Robert P Baughman, MD (4) · Iwona Stelmach, MD, PhD, Prof (3) · Jimmi Elers, MD (3) · Iwona Stelmach, MD PhD Prof (2) · Alberto M Borobia, MD, PhD (1) · Albrecht Breitenbuecher, MD (1) · Ana Luisa G Fernandes, MD, PhD (1) · Andrew Thamboo (1) · Anthony Frew, MBBS MD FRCP (1) · Barbara P Yawn, MD MSc (1) · Benjamin D. Gold, MD. (1) · Celeste Porsbjerg, MD, PhD (1) · Charles Pilette (1)
PMID 10049409, PMID 11113831, PMID 11825832, PMID 16329022, PMID 17919504, PMID 18331513, PMID 20887423, PMID 20920599, PMID 21060320, PMID 21782228, PMID 22153774, PMID 22394648, PMID 23567357, PMID 24745701, PMID 24809759, PMID 25419479, PMID 26142551, PMID 26247167, PMID 26426817, PMID 26513622, PMID 26685124, PMID 28353116, PMID 29531100, PMID 30009819, PMID 30696670, PMID 30708107, PMID 33076885, PMID 34363816, PMID 34744427, PMID 36217131, PMID 36806068, PMID 37429687, PMID 39746515, PMID 40387020, PMID 41309110, PMID 42006631
2019 (2), 2005 (1), 2017 (1)